Sandy Spring Bank’s Tandem Diabetes Care TNDM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-40
Closed -$1.62K 1268
2023
Q1
$1.62K Hold
40
﹤0.01% 1042
2022
Q4
$1.8K Hold
40
﹤0.01% 1029
2022
Q3
$2K Buy
40
+25
+167% +$1.37K ﹤0.01% 1058
2022
Q2
$1K Hold
15
﹤0.01% 1109
2022
Q1
$2K Sell
15
-85
-85% -$9.92K ﹤0.01% 1071
2021
Q4
$15K Hold
100
﹤0.01% 821
2021
Q3
$12K Buy
+100
New +$11K ﹤0.01% 849
2020
Q3
Sell
-25
Closed -$2K 987
2020
Q2
$2K Buy
25
+5
+25% +$399 ﹤0.01% 839
2020
Q1
$1K Buy
+20
New +$1.4K ﹤0.01% 882

Other funds holding TNDM

Sandy Spring Bank's TNDM Position: Q2 2023 in Review

Sandy Spring Bank sold out of Tandem Diabetes Care (TNDM) in Q2 2023, closing a stake of 40 shares — an estimated $1.62K sold.

Sandy Spring Bank first reported a position in TNDM in Q1 2020 and held it in 9 quarters. The position peaked at $15K in Q4 2021. 247 funds tracked by Wall St. Rank hold TNDM as of Q2 2023.

  • Sandy Spring Bank reported no remaining Tandem Diabetes Care position as of Q2 2023 after selling out during the quarter.
  • Sandy Spring Bank sold 40 Tandem Diabetes Care shares in Q2 2023, an estimated $1.62K.
  • Sandy Spring Bank first reported a position in Tandem Diabetes Care in Q1 2020 and held it in 9 quarters.
  • Sandy Spring Bank's Tandem Diabetes Care position peaked at $15K in Q4 2021.
  • 247 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2023.

Based on Sandy Spring Bank's 13F filing for Q2 2023, filed 4 Aug 2023.